Upload
Featured Recent Articles Topics Upload Login Sign Up

Search Results for 'placebo event'

placebo event published presentations and documents on DocSlides.

Placebo (n = 2,333) Empaglifozin
Placebo (n = 2,333) Empaglifozin
by SugarPlumFairy
(. n . = 4,687). EMPA-REG OUTCOME. Primary . outco...
ASCEND Randomized placebo-controlled trial of aspirin 100 mg daily in 15,480 patients with diabetes and no baseline cardiovascular
ASCEND Randomized placebo-controlled trial of aspirin 100 mg daily in 15,480 patients with diabetes and no baseline cardiovascular
by mitsue-stanley
ASCEND Randomized placebo-controlled trial of as...
Landmark statin trials a
Landmark statin trials a
by hadly
cross . the . spectrum . of . risk. : . Secondary ...
Have the OPTIMOX-2, CAIRO-3, COIN, DREAM and other recent t
Have the OPTIMOX-2, CAIRO-3, COIN, DREAM and other recent t
by sherrill-nordquist
Yes . Deborah . Schrag. , MD, MPH. No. John L. Ma...
Long-Term Tolerability of
Long-Term Tolerability of
by briana-ranney
Ticagrelor. for Secondary Prevention: . Insights...
CV safety & Outcome trials of
CV safety & Outcome trials of
by aaron
Oral . Antidiabetics. Adverse CV events led the F...
Apixaban vs VKA and
Apixaban vs VKA and
by cheryl-pisano
Apixaban vs VKA and Aspirin vs Placebo in Patie...
PPAR ļ§ activation Clinical
PPAR ļ§ activation Clinical
by maniakti
evidence. Evolution of clinical evidence supportin...
CETP inhibition : Where
CETP inhibition : Where
by rodriguez
are we . now. ?. Prof. John Kastelein. Academic. ...
Diabetes treatment options
Diabetes treatment options
by StarDust
Dr Theingi Aung. Endocrinologist. Royal Berkshire ...
Evidence Based Medicine In
Evidence Based Medicine In
by megan
Pharmacy Practice. Jarrod King, Pharm. D. . PGY1 U...
A Randomized Controlled Trial of Influenza Vaccine to Prevent Adverse Vascular Events (I
A Randomized Controlled Trial of Influenza Vaccine to Prevent Adverse Vascular Events (I
by genevieve
Mark Loeb MD. Professor, McMaster University . @ML...
Cardiovascular outcomes
Cardiovascular outcomes
by lois-ondreau
Silvio E Inzucchi. Professor of . Medicine. , . Y...
Reduction in Ischemic Events with
Reduction in Ischemic Events with
by natalia-silvester
Ticagrelor. in Diabetic Patients from the PEGASU...
Reduction in Ischemic Events with Ticagrelor in
Reduction in Ischemic Events with Ticagrelor in
by liane-varnes
Reduction in Ischemic Events with Ticagrelor in Di...
Efficacy and safety of upadacitinib in patients with active ankylosing spondylitis: 1-year results
Efficacy and safety of upadacitinib in patients with active ankylosing spondylitis: 1-year results
by megan
double-blind, placebo-controlled study with open-l...
x0000x0000 xAttxachex
x0000x0000 xAttxachex
by ani
�� ��NDA 20-839...
Evidence Synthesis
Evidence Synthesis
by jalin
Number 37 Genetic Risk Assessment and BRCA Mutati...
Prevention of Serious Adverse Events Following Angiography (PRESERVE) Trial
Prevention of Serious Adverse Events Following Angiography (PRESERVE) Trial
by OneAndOnly
VA Cooperative Studies Program Trial # 578. Contra...
A GLP-1 Receptor Agonist CV Outcomes Trial
A GLP-1 Receptor Agonist CV Outcomes Trial
by BadassBabe
Final Results. Background. Trends in the Prevalenc...
T icagrelor W ith Asp I
T icagrelor W ith Asp I
by terrificycre
rin or A. L. one . I. n Hi. GH. -Risk Patients Aft...
Protecting the heart and the kidney:
Protecting the heart and the kidney:
by pressio
Implications from the SHARP trial. Dr. Christina R...
PCSK-9 Inhibitors Paul J
PCSK-9 Inhibitors Paul J
by tatyana-admore
PCSK-9 Inhibitors Paul J Kovack , DO, FACC, FACO...
New developments in lipid management
New developments in lipid management
by pasty-toler
CGR 0800 h 11 May 2015. Rob Hegele MD FRCPC FACP....
Cardiovascular Disease in Women: Update on Menopausal
Cardiovascular Disease in Women: Update on Menopausal
by briana-ranney
Hormone Therapy and Selective Estrogen Receptor M...
FOURIER F urther cardiovascular
FOURIER F urther cardiovascular
by trish-goza
OU. tcomes. . R. esearch with PCSK9 . I. nhibiti...
Cholesterol Treatment Trialistsā€™ (CTT) Collaboration
Cholesterol Treatment Trialistsā€™ (CTT) Collaboration
by briana-ranney
Slide deck. CTT Collaboration: Background*. Histo...
The EINSTEIN EXT Study 'Xarelto' for
The EINSTEIN EXT Study 'Xarelto' for
by tatiana-dople
the . Long-Term Prevention of Recurrent Venous Th...
Short- and Long-Term Effect
Short- and Long-Term Effect
by lindy-dunigan
of Immediate Vasodilator Therapy. in Acutely Deco...
The results of the SHARP trial
The results of the SHARP trial
by stefany-barnette
SHARP: Rationale. Risk of vascular events is high...
Perioperative
Perioperative
by pasty-toler
Aspirin & . POISE-2. Neal Gerstein, MD FASE. ...
Protecting the heart and the kidney:
Protecting the heart and the kidney:
by marina-yarberry
Implications from the SHARP trial. Dr. Christina ...